SAR256212
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR256212, covering 2014-06-13 to 2014-06-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers [Phase 1]